NeuroDerm (NDRM) Misses Q2 EPS by 12c

NeuroDerm (NASDAQ: NDRM) reported Q2 EPS of ($0.44), $0.12 worse than the analyst estimate of ($0.32).

As of June 30, 2016, the Company had cash and cash equivalents and short-term bank deposits totaling $89.8 million.

For earnings history and earnings-related data on NeuroDerm (NDRM) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance